The QualityStocks Daily Monday, February 24th, 2020

Today's Top 3 Investment Newsletters

QualityStocks (COCP) +166.53%

BUYINS.NET (LPCN) +67.03%

SmallCapRelations (NSRI) +46.55%

The QualityStocks Daily Stock List

Cardiff Lexington Corporation (CDIX)

OTC Markets, Speculating Stocks, Spotlight Growth, Street Insider, Simply Wall St, Nasdaq, last10k, Investing.com, OTC Dynamics, GuruFocus, Dividend Investor, Stockhouse, Market Wire News, Barchart, Seeking Alpha, Market Exclusive, New Media Wire, Wallet Investor, Market Screener, Morningstar, Investors Hangout, InvestorsHub and GlobeNewswire reported earlier on Cardiff Lexington Corporation (CDIX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Cardiff Lexington Corporation acquires or merges with middle market companies by providing them the ability to have an infusion of equity into their business or providing them the ability to exit equity out of their company. Cardiff Lexington’s emphasis is not industry or geographic-specific. The Company’s focus is proven management, market, as well as margin. Cardiff Lexington has its corporate headquarters in Ft. Lauderdale, Florida. The Company lists on the OTC Markets.

Regarding Target Acquisitions, Cardiff Lexington targets acquisitions of mature, high growth, niche companies. Its target companies' proven management maintains complete operational control. Therefore, Cardiff’s acquisitions become standalone autonomous subsidiaries that gain the advantages of a public company without losing their operational independence.

For Investors, Cardiff Lexington works to aggressively grow and hold assets that create a diversified lower risk environment that over the long term protects and safely enhances investment by continually adding assets and holdings via acquisitions to a diversified continually growing niche holding company. Cardiff acquires companies with significant assets and little to no debt while continuing to grow Cardiff Lexington and its underlying market value.

The Company’s growth emphasis by way of perpetual acquisitions focuses on serving the successful business owner in three main categories. This is while also including varied and synergistic industries such as healthcare, technology, as well as food and beverage.

Cardiff Lexington’s target composition of holdings over time are targeted to represent 40 percent income producing commercial real estate companies; 40 percent small to mid-sized privately held companies; and 20 percent second stage startups - emerging growth companies.

Recently, Cardiff Lexington announced that Mr. Steven Healy, CPA agreed to join the Senior Management Team as the Company’s Chief Financial Officer (CFO). As Cardiff Lexington’s first in-house CFO, Mr. Healy brings to Cardiff Lexington more than 25 years’ progressive public and private company experience in finance and operations management.

Mr. Alex H. Cunningham, Cardiff Lexington Chief Executive Officer, stated, “This is a major milestone for Cardiff Lexington. It is significant leap forward for our organization as we transition from outsourced accounting consolidation. Steven has extensive hands-on experience with both Private and Public SEC Reporting Companies and a track record of developing and implementing uniform accounting policies, procedures and systems…”

Cardiff Lexington Corporation (CDIX), closed Monday's trading session at $0.0004, even for the day, on 15,497,101 volume with 29 trades. The average volume for the last 3 months is 18,115,943 and the stock's 52-week low/high is $0.0003/$0.75.

chart

Cordoba Minerals Corp. (CDBMF)

Penny Stock Hub, Northern Miner, Macroaxis, GlobeNewswire, Dividend Investor, YCharts, Stockhouse, Dividend.com, Stock Day Media, Mining Stock Valuator, OTC Markets, Equities, Investing News, Morningstar, Proactive Investors, Wallet Investor, OTC.Watch, Investors Hangout, Seeking Alpha, Nasdaq, Geology for Investors, Market Screener, MarketWatch, Junior Mining Network, and Investor Ideas reported beforehand on Cordoba Minerals Corp. (CDBMF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Cordoba Minerals Corp. is a mineral exploration company focused on the exploration, development and acquisition of copper and gold projects. It is exploring the San Matias Copper-Gold-Silver Project. This Project includes the Alacran deposit and satellite deposits at Montiel East, Montiel West and Costa Azul, located in the Department of Cordoba, Colombia. Incorporated in 2009, Cordoba Minerals has its corporate office in Vancouver, British Columbia. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Cordoba Minerals also holds a 25 percent interest in the Perseverance porphyry copper project in Arizona that it is exploring through a Joint Venture (JV) and Earn-In Agreement. In July of 2017, the Company acquired a 100 percent ownership interest in the San Matias Copper-Gold-Silver Project from High Power Exploration, Inc. (HPX). HPX is a privately owned, metals-focused exploration company led by mining entrepreneur Mr. Robert Friedland. HPX owns a roughly 70 percent interest in Cordoba Minerals.

The San Matias Copper-Gold-Silver Project comprises a 20,000 hectare land-package. It contains several known areas of porphyry copper-gold and iron oxide copper gold, and/or carbonate replacement deposit mineralization and gold veins. The Project is positioned close to sea-level in an established mining district with premier access and infrastructure.

The San Matias Project is an early stage exploration project. Cordoba Minerals is exploring a newly identified high grade copper-gold district that is characterized by porphyry type and “carbonate replacement” (CRD) type and/or “iron oxide copper-gold” (IOCG) type deposits formed in an accreted island arc setting.

Last month, Cordoba Minerals announced its upcoming work program for 2020 at the San Matias Copper-Gold-Silver Project in Colombia and the Perseverance Copper Project in Arizona. At San Matias, the Company plans to accelerate development of the Alacran deposit. It has started the Pre-Feasibility studies required to secure the necessary Colombian mining approvals. In addition, Cordoba will pursue further exploration in the San Matias district. This includes advancing the search for the porphyry sources of the Alacran and Montiel West deposits.

At its Perseverance Copper Project that it is exploring via a Joint Venture (JV) and Earn-In Agreement with Bell Copper Corporation, Cordoba Minerals has started a magneto-telluric (MT) geophysical survey. The aim of this MT survey is to close off the earlier-identified strong conductivity anomaly thought to reflect the southwestern edge of a concealed porphyry system.

Cordoba Minerals Corp. (CDBMF), closed Monday's trading session at $0.0762, up 8.8571%, on 31,000 volume with 6 trades. The average volume for the last 3 months is 22,543 and the stock's 52-week low/high is $0.02666/$0.10621.

chart

GBT Technologies, Inc. (GTCH)

Zacks, Real Investment Advice, OTC.Watch, Street Insider, Market Screener, VentureLine, Wallet Investor, Investing.com, Investors Hangout, Simply Wall St, Stockhouse, Nasdaq, Stockwatch, Investor Ideas, GlobeNewswire, TipRanks, GuruFocus, InvestorsHub, last10k, and PR Newswire reported earlier on GBT Technologies, Inc. (GTCH), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

GBT Technologies, Inc. specializes in the development of Internet of Things (IoT) and Artificial Intelligence (AI) enabled networking and tracking technologies. A development-stage enterprise, the Company has a portfolio of Intellectual Property (IP) that, upon commercialization, will include smart microchips, mobile and security applications and protocols, and supporting cloud software. The Company previously went by the name Gopher Protocol, Inc. It changed its name to GBT Technologies, Inc. in August of 2019. Formed in 2009, GBT Technologies has its head office in Santa Monica, California.

The Company’s system foresees the creation of a worldwide mesh network. The heart of this system will be its advanced microchip technology that can be installed in any mobile or fixed device globally. GBT Technologies envisions the system as a low-cost, secure, private mesh network between any enabled devices, providing shared processing, advanced mobile database management/sharing, and enhanced mobile features as an alternative to traditional carrier services.

GBT’s Core Technology is a pioneering new platform with products that will change the way people interact with technology and each other. The Platform Technology is called GopherInsight™. It uses “public” RF spectrum to facilitate a private network between enabled devices. Products that use GopherInsight™ can have network access without using traditional Bluetooth, Cellular or Satellite connectivity.

GBT Technologies has entered into a Joint Venture (JV) Agreement with BitSpeed LLC. The new JV is called GBT BitSpeed Corp. BitSpeed is a software development company located in the Los Angeles, California area. BitSpeed specializes in the development, sale and maintenance of software that allows the accelerated and secure transfer of large file data over existing private or public networks.

The expectation is that GBT BitSpeed Corp. will assist with the integration and development of BitSpeed’s technology into GBT’s patented and patent-pending technology platform outlined in earlier announcements, highlighted by its GopherInsight, gNET Wireless Mesh Network platform, and its Avant! AI management system. As GBT’s gNET network data transfer needs grow in the future, it is planned that a high-speed, secure layer of technology could be added to facilitate movement of large file data worldwide.

GBT Technologies, Inc. (GTCH), closed Monday's trading session at $0.078, off by 31.2169%, on 371,375 volume with 95 trades. The average volume for the last 3 months is 74,153 and the stock's 52-week low/high is $0.075999997/$55.50.

chart

Granada Gold Mine, Inc. (GBBFF)

GuruFocus, 24hgold, Dividend Investor, YCharts, Investing News, Streetwise Reports, OTC Markets, Junior Mining Network, Morningstar, Seeking Alpha, Wallet Investor, The Stock Market Watch, Market Screener, Stockwatch, Nasdaq, Stockhouse, TradingView, Barchart, Smart Stock Trading Strategies, 4-Traders, Investors Hangout, AA Stocks, and Online PR News reported earlier on Granada Gold Mine, Inc. (GBBFF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Granada Gold Mine, Inc. is a junior mining and exploration company with Gold properties in the Province of Quebec. Its present emphasis is the development and continued exploration of the Granada Property located in the heart of the famous Abitibi Greenstone Belt and along the prolific "Cadillac Trend". This potential high tonnage, near-surface deposit is situated 15 minutes from Rouyn-Noranda, Quebec. Granada Gold Mine is based in Rouyn-Noranda.

About 120,000 meters of drilling has been completed so far on the Granada Gold Property. This drilling has centered primarily on the extended LONG Bars zone that trends 2 kilometers east-west over a potential 5.5 kilometers of mineralized structure. The highly prolific Cadillac Break, the source of over 75 million plus ounces of gold production in the past century, cuts through the north part of the Granada property.

In January, Granada Gold Mine provided assays results from the last hole in the latest drill program at its 100 percent-owned Granada gold deposit in Rouyn-Noranda. Unexpected near-surface, high-grade mineralization was discovered within the recently explored two-kilometer LONG Bars Zone of the five and half kilometer Granada Shear zone that trends east-west on the property. The 450-meter Fall 2019 drill program centered on testing the gold grade continuity and variability within mineralized structures.

Highlights include 11.45 g/t in drill hole GR-19-A from 0 to 33 m core length. This includes high-grade intercepts of 42.5 g/t from 0 to 1.5 m, 480 g/t from 8.1 to 8.5 m, and 70.8 g/t from 31.9 to 32.4 m. The horizontal width, based on outcrop, is approximately 9 meters and true width is estimated at 6.3 meters.

The core length reported is estimated to have intersected only 15-20 percent of the entire thickness of the zone. Nonetheless, it is a real known extent in that direction down dip of gold mineralization within the intersected length. Assays are uncut except where indicated. A further 50 m strike length of stripping uncovered a massive mineralized quartz zone exposing strong veining with visible gold on surface.

Additionally, in January, Granada Gold Mine announced it will commence a bulk sampling program this spring on the high-grade, mineralized structures exposed at surface. The design of this program will be to evaluate the native gold component in the mineralized structures.

A metallurgical program was undertaken in 2012 at SGS Lakefield Gold Metallurgical Testing Group, Ontario. This study concluded that, based on 29 composite samples, the native gold component ranged from 29.6 percent to 78 percent, with an average of 54.0 percent that can be recovered by simple gravity means (NI 43-101 PEA, February 4, 2013, effective date December 21, 2012).

Granada Gold Mine, Inc. (GBBFF), closed Monday's trading session at $0.1127, off by 5.9265%, on 20,469 volume with 7 trades. The average volume for the last 3 months is 32,895 and the stock's 52-week low/high is $0.060199998/$0.165000006.

chart

Nevada Exploration, Inc. (NVDEF)

Streetwise Reports, Resource World, Hot Stocked, OTC Dynamics, Penny Stock Hub, OTC Markets, Market Wire News, Metals News, Stock Day Media, 24hgold, Journal Transcript, YCharts, Wallet Investor, Stockhouse, and Dividend.com reported previously on Nevada Exploration, Inc. (NVDEF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Nevada Exploration, Inc. is an exploration company advancing a portfolio of new district-scale Carlin-type gold projects in north-central Nevada. An experienced management team that has been involved in several important discoveries in Nevada, including the discovery of Lone Tree and Rabbit Creek (now part of the Twin Creeks Mine) leads Nevada Exploration. The Company’s team has spent the last 10 years integrating the use of hydrogeochemistry with conventional exploration tools to develop a Nevada-specific regional-scale geochemistry exploration program. OTCQB-listed, Nevada Exploration is based in Vancouver, British Columbia.

With new proprietary technology, Nevada Exploration has completed the world’s largest groundwater sampling program for gold exploration, collecting roughly 6,000 samples to evaluate Nevada’s covered basins for new gold exploration targets. Through integrating hydrogeochemistry with conventional exploration methods, the Company is leading the industry to open this important new search space to explore for large new Carlin-type gold deposits.

Nevada Exploration’s projects include South Grass Valley, Grass Valley, and Kelly Creek. Its South Grass Valley Project is positioned approximately 50 kilometers south-southwest of Barrick Gold Corp.’s Cortez complex, within the specific area of north-central Nevada known for Carlin-type gold deposits (CTGDs). The Grass Valley Project is situated along the western edge of Grass Valley, the valley basin that continues south from Barrick Gold’s Cortez complex (Pipeline, Cortez Hills, and Goldrush). The Kelly Creek Project is located along the Battle Mountain-Eureka Trend within the prolific Kelly Creek Basin, between multi-million-ounce CTGDs at the north and south ends of the Basin.

Recently, Nevada Exploration provided an update pertaining to its continuing reverse-circulation (RC) drilling program at its South Grass Valley Carlin-type gold project. Shortly after starting the program on January 6, 2020, the Company mobilized a second drill rig to the Project. It has now drilled a total of 2,146 meters. Based on preliminary geologic logging, Nevada Exploration reported that the additional drill holes are improving the resolution of and its confidence in its exploration model at the Project.

Nevada Exploration, Inc. (NVDEF), closed Monday's trading session at $0.2501, up 0.863042%, on 289,849 volume with 65 trades. The average volume for the last 3 months is 105,546 and the stock's 52-week low/high is $0.112599998/$0.303090006.

chart

Q BioMed, Inc. (QBIO)

NetworkNewsWire, Zacks, Insider Financial, Market News Updates, last10k, TipRanks, Barchart, Market Screener, MacroTrends, Wallet Investor, InvestorsHub, Stockhouse, Stockwatch, PR Newswire, Simply Wall St, Proactive Investors, MarketBeat, and Emerging Growth reported beforehand on Q BioMed, Inc. (QBIO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Q BioMed, Inc. is a biotechnology acceleration company listed on the OTC Markets Group’s OTCQB. It acquires, develops and finances undervalued biomedical assets. The Company’s vision is to create a pipeline of innovative biomedical assets in various stages of development in manifold therapeutic areas. Its Food and Drug Administration (FDA) approved, non-opioid drug is Metastron. Q BioMed is headquartered in New York, New York.

Q BioMed’s Metastron relieves cancer bone pain. Metastron is approved for sale in 21 other countries. Further to treating pain, Metastron has shown evidence of treating the cancer itself and extending survival. Q BioMed’s plan is to conduct Phase IV trials to support label extension and cancer survival benefit using Metastron.

In addition, the Company has its Uttroside-B. Uttroside-B is up to 10 times more potent against liver cancer cells than Sorafenib (preclinical data), the only FDA approved drug for first line treatment of liver cancer. Furthermore, the Company has its QBM-001 for Pediatric Non-Verbal Disorder in dire need of treatment.

Q BioMed also has its Man-01 to treat glaucoma. Man-01 has shown to normalize Intraocular Eye Pressure (IOP) that is present in glaucoma patients. The Mannin platform has several potential drugs for treating vascular disease.

This month, Q BioMed announced the launch of its FDA approved non-opioid drug Strontium89 (Strontium Chloride Sr-89 Injection, USP). This drug has been shown in clinical studies to help relieve persistent pain associated with cancer that has metastasized to bone.

In a number of multicenter, placebo-controlled trials in cancer patients with persistent pain after external beam radiation therapy for bone metastases, pain relief occurred in more patients treated with a single injection of Strontium89 than in patients treated with an injection of placebo, with a greater percentage of patients experiencing pain scores of zero without any need for opioid or non-opioid rescue analgesics. Duration of pain palliation has been shown to range from 2 to 5 months in most patients.

Strontium89 can be redosed every 90 days. Q BioMed plans to launch the drug in international markets, including Europe, in the coming quarters. Moreover, the Company is planning further research for Strontium89 for potential label extension into therapeutic use for survival benefit in metastatic bone cancer through a Phase IV study.

Q BioMed, Inc. (QBIO), closed Monday's trading session at $3.1, off by 1.8987%, on 281,491 volume with 428 trades. The average volume for the last 3 months is 179,360 and the stock's 52-week low/high is $0.34009999/$3.75.

chart

Smith-Midland Corporation (SMID)

Zacks, Stocks To Buy Now, StockInvest.us, Glassdoor, TradingView, Wallet Investor, MarketBeat, GEO Investing, ValueWalk, TipRanks, Market Screener, Funding Universe, Investing.com, 4-Traders, GuruFocus, Last10k, Stockopedia, TMXmoney, Stockhouse, InvestorsHub, Nasdaq, Simply Wall St, GlobeNewswire, and Emerging Growth reported beforehand on Smith-Midland Corporation (SMID), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Smith-Midland Corporation develops, manufactures, and sells a broad array of precast concrete products for use primarily in the construction, transportation, and utilities industries. The Company has three manufacturing facilities located in Midland, Virginia; Reidsville, North Carolina; and Columbia, South Carolina. Established in 1960, Smith-Midland is based in Midland, Virginia. The Company lists on the OTC Markets Group’s OTCQX.

Easi-Set Worldwide is a wholly-owned subsidiary of Smith-Midland Corporation. Easi-Set Worldwide licenses the production and sale of Easi-Set products, including J-J Hooks, and provides diversification opportunities to the precast industry around the world.

Concrete Safety Systems (CSS) is Smith-Midland’s safety barrier rental division. CSS is supplied by Smith-Midland’s three production facilities. CSS provides concrete safety barrier rental for highway construction and other projects across its mid-Atlantic and Southeast market area. CSS serves its regional clients through a network of seven rental yards.

The above-mentioned J-J Hooks is the most popular barrier connection design in North America. It continues to play a leadership role in safety innovation for the highway construction industry. More than 15,000,000 linear feet of J-J Hooks temporary barrier have been produced and installed globally, since its introduction in 1990.

Smith-Midland’s manufacturing plants include steel shops, form fabrication shops, automated concrete batch plants, and environmentally controlled casting areas. Among the Company’s major innovations are J-J Hooks positive connection safety barriers; SoftSound, a sound absorbing concrete for highway sound barrier; and Easi-Set/Easi-Span Precast Buildings with post-tensioned roofs & floors. Additionally, major innovations include SlenderWall architectural building panels and Beach Prisms Shoreline erosion control product.

Recently, Smith-Midland’s Easi-Set Worldwide subsidiary announced the addition of Summit Precast, LLC to its family of J-J Hooks precast concrete safety barrier licensed producers. Summit Precast, LLC (Montgomery, Texas) is owned by the Ogorchock family. The Ogorchock's have years of prior precast concrete barrier manufacturing experience. Summit Precast will be serving chiefly the Houston to San Antonio highway barrier market area.

Smith-Midland’s Easi-Set Worldwide subsidiary will be exhibiting at The Precast Show March 5-7, 2020 in Fort Worth, Texas. The Precast Show is sponsored by the National Precast Concrete Association and the Precast/Prestressed Concrete Institute with additional collaboration from the Canadian Precast/Prestressed Concrete Institute and the Cast Stone Institute. It is the largest precast-specific trade show in North America.

Smith-Midland Corporation (SMID), closed Monday's trading session at $5.98, off by 2.447%, on 5,507 volume with 31 trades. The average volume for the last 3 months is 12,380 and the stock's 52-week low/high is $5.3499999/$9.52999973.

chart

Quantum Computing, Inc. (QUBT)

Tip Ranks, Proactive Investors, Last10k, Market Wire News, InvestorsHub, Stockopedia, Wallet Investor, Stockhouse, Simply Wall St, and GlobeNewswire reported earlier on Quantum Computing, Inc. (QUBT), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Quantum Computing, Inc. is a technology company listed on the OTC Markets Group’s OTCQB. It centers on developing novel applications and solutions utilizing quantum and quantum-inspired computing to solved difficult problems in diverse industries. The Company was previously known as Innovative Beverage Group Holdings, Inc. Quantum Computing has its corporate headquarters in Leesburg, Virginia.

Quantum is leveraging its collective expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial and security sectors. It is developing an array of software applications capable of running on quantum and quantum-inspired hardware from manifold vendors. The Company’s initial focus is on the creation of Quantum Finance applications.

Quantum Computing has put together a world-class team of experts in supercomputing, technology, defense, as well as government. This team is working to develop solutions to world-class problems. It is developing processes to commercialize advances in quantum computing.

Recently, Quantum Computing announced that it was admitted to the National Institute of Standards and Technology (NIST)-supported Quantum Economic Development Consortium. The Quantum Economic Development Consortium or QED-C is managed by SRI International. QED-C is a government and industry supported initiative to foster collaboration and expand U.S. leadership in the worldwide quantum information science and technology economy.

QED-C members will collaborate on precompetitive research and development (R&D) including quantum device design and prototyping. They will also increase efficiencies while sharing resources, and leverage their own research investments with those of the federal government and other members.

Mr. Robert Liscouski, Quantum Computing Chief Executive Officer, said, “I’m honored to have Quantum Computing, Inc. join the QED-C. I believe our participation will allow us to contribute to an important government initiative and create partnerships with key players and thought leaders in the quantum computing industry.”

Quantum Computing will be presenting at this year's Fall Investor Summit on September 16th-17th in New York, New York. The Fall Investor Summit will take place at the Essex House, featuring 160 companies and more than 1,000 institutional and retail investors.

Quantum Computing, Inc. (QUBT), closed Monday's trading session at $5.97, up 79.2793%, on 33,252 volume with 167 trades. The average volume for the last 3 months is 2,285 and the stock's 52-week low/high is $1.67999994/$7.50.

chart

STR Holdings, Inc. (STRI)

Zacks, Street Insider, GlobeNewswire, StockInvest, 4-Traders, Real Investment Advice, Capital Cube, and Wallet Investor reported beforehand on STR Holdings, Inc. (STRI), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

STR Holdings, Inc. is a worldwide provider of high quality, superior performance encapsulants for the photovoltaic (PV) module industry. It pioneered the solar encapsulant market over three decades ago with the invention of EVA encapsulant. STR Holdings, Inc. is a subsidiary of Zhen Fa New Energy (U.S.) Co., Ltd. Established in 1944, STR Holdings has its head office in Enfield, Connecticut. The Company has manufacturing locations in the U.S, Spain, and Malaysia.

STR Holdings designs, develops, and manufactures encapsulants, which protect the embedded semiconductor circuits of solar panels for sale to solar module manufacturers. The Company also designs, develops, and manufactures multi-layer films for packaging applications, such as meat, fish, cheese, yogurt, fruit, cereals, snack foods, and more. STR’s encapsulants can be used in crystalline silicon and thin-film solar modules.

Ethylene Vinyl Acetate (EVA) has been the chief material used in solar encapsulants for the last few decades. STR PHOTOCAP® EVA is the only encapsulant technology with a proven track record of maintaining durability, adhesion, stability and transparency after greater than 30 years of field exposure. STR works directly with its customers to improve their lamination processes and subsequently, improve the quality of their modules, increase yield and lessen costs.

More than 20 Gigawatts of STR Protected™ Modules are in the field. Encapsulant reliability necessitates accurate, repeatable formulation, premier quality raw materials and strict process control. First-rate long-term optical performance of STR Encapsulant facilitates maximum power output. STR Encapsulant touches every component of the solar module. Therefore, it must be chemically and physically compatible to enhance module durability.

STR Protected includes user-friendly no shrink technology during the manufacturing of its encapsulant. This means zero shrink and no adverse impact on adhesion to glass, cell or backsheet, which can harm modules in the field.

STR Holdings has its PHOTOCAP® encapsulant. The Company’s products range from its traditional standard and fast cure grades to industry leading ultra-fast and mega-fast cure encapsulants to optimize module production throughput. Products include PHOTOCAP® 15580P for use in front or in back of cells, and PHOTOCAP® 15585P HLT™ for use in front of cells. PHOTOCAP® products also include PHOTOCAP® 15585S HLT™ for use in front of cells; PHOTOCAP® 35530P - ultra-fast cure kinetics; and PHOTOCAP® 35521P HLT™ - ultra-fast cure kinetics.

STR Holdings, Inc. (STRI), closed Monday's trading session at $0.17, up 17.0799%, on 182,272 volume with 17 trades. The average volume for the last 3 months is 20,490 and the stock's 52-week low/high is $0.07/$0.388000011.

chart

Upper Street Marketing, Inc. (UPPR)

NetworkNewsWire, OTC.Watch, OTC Markets, Financial Buzz, Street Insider, Emerging Growth, Investor Ideas, Wallet Investor, Proactive Investors, Dividend Investors, Stockwatch, News to Watch, Investors Hangout, and Stockopedia reported earlier on Upper Street Marketing, Inc. (UPPR), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Upper Street Marketing, Inc. is one of the only companies in the world to control every phase of the cannabidiol (CBD) extraction cycle from seed to consumer. The Company’s intention is to be a leader in FDA cGMP (Current Good Manufacturing Practice) capabilities in the hemp and CBD marketplace. It is established and entrenched in the Colorado hemp marketplace with significant opportunities for organic expansion and synergistic mergers and acquisitions. Upper Street Marketing’s wholly-owned subsidiary is Growing Springs Holdings Corporation.

Upper Street Marketing is under contract to cultivate 360 acres of hemp for 2019 and beyond. The Company owns a 100,000 square foot facility for processing Cannabidiol or CBD from hemp in Center, Colorado. Its plan is to be able to grow and process up to 1,000,000 pounds of bio-mass in 2019 and up to 4,000,000 pounds of bio-mass in 2020.

In addition, Growing Springs Holdings /Upper Street Marketing is negotiating an additional 3,000 acres of hemp for cultivation in Colorado for 2020 – 2023. The Company has leased a 13,000 square foot CBD approved laboratory facility in San Diego, California for the processing of CBD extracts. It will look to install capacity to produce 100,000 kilos annually of CBD Isolate over the next 36 months.

Upper Street Marketing (UPPR) and its subsidiary Growing Springs Holdings entered into an agreement to process 1.5 million pounds of hemp biomass into cannabidiol (CBD) isolates and distillates with a value of about $200 million. Fox Organic Farms will deliver the biomass from its 830-acre Saguache, Colorado cultivation to UPPR-affiliated extraction facilities in October, where it will undergo conversion into pharmaceutical-grade CBD products in exchange for a 50 percent share of the revenue.

Upper Street Marketing recently announced the closing of its recently announced acquisition of twenty percent of Catch Capital Partners, Inc. The Company issued five million shares to the Principals of Catch Capital Partners. Catch Capital Partners is a Canadian company advancing projects in the outdoor cannabis and hemp space.

Upper Street Marketing, Inc. (UPPR), closed Monday's trading session at $0.10, up 400.00%, on 2,120 volume with 4 trades. The average volume for the last 3 months is 2,688 and the stock's 52-week low/high is $0.219999998/$2.22250008.

chart

GeoVax Labs, Inc. (GOVX)

StreetWise Reports, Zacks, Street Insider, Investor Village, Stock News Now, Micro Cap Daily, OTC Markets, Stockwatch, Marketbeat, Real Investment Advice, InvestorsHub, Stockhouse, and Proactive Investors reported previously on GeoVax Labs, Inc. (GOVX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, GeoVax Labs, Inc. is a biotechnology company developing human vaccines. The Company is developing human vaccines against infectious diseases and cancer using a novel patented Modified Vaccinia Ankara-Virus Like Particle (MVA-VLP) based vaccine platform. GeoVax Labs current development programs are centered on preventive vaccines against HIV, Zika Virus, hemorrhagic fever viruses (Ebola, Sudan, Marburg, and Lassa), and malaria, and also therapeutic vaccines against chronic Hepatitis B infections and numerous cancers. GeoVax Labs has its head office in Smyrna, Georgia.

MVA is a large virus capable of carrying a number of vaccine antigens. On the platform, MVA expresses proteins that assemble into VLP immunogens within (in vivo) the person receiving the vaccine. The production of VLPs in the person being vaccinated mimics virus production in a natural infection, stimulating the humoral and cellular arms of the immune system to recognize, prevent, and control the target infection. The MVA-VLP derived vaccines elicit durable immune responses in the host alike to a live-attenuated virus. This is while providing the safety characteristics of a replication-defective vector.

GeoVax Labs has designed the leading preventative HIV vaccine candidate to fight against the subtype of HIV predominant in the larger commercial markets of the Americas, Western Europe, Japan, and Australia. At present, this program is undergoing human clinical trials managed by the HIV Vaccine Trials Network (HVTN) with the support of the National Institutes of Health (NIH). Additionally, the Company’s HIV vaccine is part of collaborative efforts to develop an immunotherapy as a functional cure for HIV.

Recently, GeoVax Labs announced its observance of HIV Vaccine Awareness Day on May 18, 2019. HIV Vaccine Awareness Day is observed each year to recognize the many volunteers, community members, health professionals, and scientists working to develop a vaccine to prevent HIV. Furthermore, it is an opportunity to educate communities about the importance of preventive HIV vaccine research.

GeoVax Labs also recently announced that it will be engaged in corporate partnering meetings during the BIO International Convention, to take place in Philadelphia, Pennsylvania on June 3-6, 2019. The Company was selected by the National Institutes of Health (NIH) and BIO to exhibit and showcase its technology in a high-profile area of the exhibition floor branded as the Innovation Zone, dedicated to recipients of NIH SBIR/STTR grants.

GeoVax Labs, Inc. (GOVX), closed Monday's trading session at $0.221, up 30.00%, on 660,561 volume with 184 trades. The average volume for the last 3 months is 42,194 and the stock's 52-week low/high is $0.115199998/$7180.00.

chart

All For One Media Corp. (AFOM)

OTC Markets, MarketWatch, Global Energy Media, Central Charts, Simply Wall St, Pink Investing, Stock Digest, Penny Stock Tweets, Street Register, Stockhouse, Financial Content, Emerging Growth, The Street, Market Exclusive, InvestorsHub, Capital Network, Proactive Investors, and Barchart reported earlier on All For One Media Corp. (AFOM), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

All For One Media Corp. is a tween marketing company listed on the OTC Markets’ OTCQB. Named “Generation I” for "Internet," this generation's tweens represent the first demographic to have had only known life with the Internet and social media. Essentially, All For One Media is a marketing brand changing the mindset of tweens that bullying is unacceptable. All For One Media has its head office in Mount Kisco, New York.

The Company is working to make the transition from a development stage corporation creating and acquiring media assets to a content provider launching many initiatives marketed to its core tween demographic. Its goal is to capitalize on a broad variety of potential revenue streams.

All For One Media, through entertainment, is working to deliver a message that will resonate with kids to impact the epidemic of bullying and cyber-bullying. In addition, it is working to help individuals who have been affected by bullying to deal with it in a positive and constructive manner.

All For One Media has produced Drama Drama (f/k/a "Crazy For the Boys"). Drama Drama is a full length coming of age musical dramedy. It features Groovy Tuesday music and choreography. This film tells the story of five high school girls from five very different cliques who must work together to run their school’s anti-bullying organization. The film features original pop songs pertaining to peer pressure, unrequited love, and teen angst. The expectation is that Drama Drama will generate revenues from numerous sources.

The Company has completed production of Drama Drama. It has started to screen the movie for buyers. Moreover, it engaged William Morris/Endeavor Content (WME) as the exclusive sales agent for the film. WME represents artists across all media platforms, particularly movies, television, music, theatre, digital and publishing.

All for One Media is making plans to commence group activities for the launch of the band "Drama Drama" concurrent to the release of the movie. The release of a full-length film used to promote the launch of a pop group is an industry first. The Company has also started negotiations with a number of major record labels for distribution of the film soundtrack.

All For One Media Corp. (AFOM), closed Monday's trading session at $0.0002, up 100.00%, on 20,050,002 volume with 6 trades. The average volume for the last 3 months is 50,974,182 and the stock's 52-week low/high is $0.000097999/$0.046999998.

chart

Cocrystal Pharma, Inc. (COCP)

Microcapmillionaires, Stock Twits, Tip Ranks, YCharts, Street Insider, Proactive Investors, MarketWatch, Stockwatch, Simply Wall St, Business Wire, Seeking Alpha, Promotion Stock Secrets, Wall Street Resources, The Street, Stockhouse, Penny Stocks Forever, GuruFocus, Equity Clock, Market Screener, Barchart, and Investors Hub reported previously on Cocrystal Pharma, Inc. (COCP), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter. 

Cocrystal Pharma, Inc. develops novel antiviral therapeutics as treatments for serious and/or chronic viral diseases. The Company uses unique technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs. The design of these technologies, including its nucleoside chemistry expertise and market-centered approach to drug discovery, are to efficiently deliver small molecule therapeutics, which are safe, effective, and convenient to administer. A biotechnology enterprise, Cocrystal Pharma is headquartered in Bothell, Washington. 

  The Company’s proprietary technologies revolve around a structure-based drug discovery strategy teamed up with extensive nucleoside experience. Utilizing techniques called protein cocrystallization and X-ray crystallography,  Cocrystal Pharma quickly identifies novel binding sites, identifies critical inhibitor-protein interactions, and optimizes the structure of the inhibitor in a highly rapid iterative fashion. The Company has identified promising, preclinical stage antiviral compounds for unmet medical needs. These include hepatitis, influenza, and norovirus infections.

Cocrystal is developing a series of compounds that are potent non-nucleoside and nucleoside inhibitors of hepatitis C NS5B RNA dependent RNA polymerase, a replication enzyme vital to viral replication and are highly conserved between all hepatitis C genotypes. Therefore, inhibitors of this enzyme are likely to have multi- or pan-genotypic activity. 

  In addition, the Company is developing compounds that inhibit hepatitis C helicase and NS5A, two enzymes important for viral replication. Cocrystal has also identified a picomolar inhibitor of NS5A; another crucial viral replication protein.

Recently, Cocrystal Pharma announced that it entered into an exclusive license and collaboration agreement with Merck to discover and develop certain proprietary influenza A/B antiviral agents. With this agreement, Merck will fund research and development (R&D) for the program, including clinical development. Merck will be responsible for global commercialization of any products derived from the collaboration. Cocrystal Pharma will be paid an undisclosed upfront sum. Cocrystal is eligible to receive payments related to designated development, regulatory and sales milestones with the potential to earn up to $156 million and undisclosed royalties on product sales.

Additionally, Cocrystal Pharma has announced safety and preliminary efficacy data for its U.S. Phase 2a study evaluating CC-31244 for the ultra-short treatment of HCV infected individuals. CC-31244 is an investigational, oral, potent, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

The treatment was well tolerated with no study discontinuations because of adverse events. Eight of 12 subjects achieved the primary efficacy endpoint of sustained virologic response at 12 weeks after completion of treatment (SVR12). SVR12 is defined as undetectable virus in blood 12 weeks after completion of treatment and considered a virologic cure.

Cocrystal Pharma, Inc. (COCP), closed Monday's trading session at $1.33, up 166.5331%, on 81,095,886 volume with 144,670 trades. The average volume for the last 3 months is 370,965 and the stock's 52-week low/high is $0.386099994/$3.24909996.

chart

WRIT Media Group, Inc. (WRIT)

SeriousTraders, Tip.us, Real Pennies, StocksToBuyNow, Pennystockmania, Great Penny Picks, and SmallCapVoice reported earlier on WRIT Media Group, Inc. (WRIT), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

WRIT Media Group, Inc. is a diversified media and software business whose shares trade on the OTC Markets. The Company’s portfolio of wholly-owned businesses includes Front Row Networks; Amiga Games; Retro Infinity, Inc.; and Pandora Venture Capital. WRIT Media Group is headquartered in Los Angeles, California.

WRIT Media’s operations include digital currency software development, including trading platforms and Blockchain solutions, content production and distribution; and video game distribution by way of mobile platforms. Its Front Row Networks produces and distributes live event programming for international digital broadcast to movie theaters and online streaming.

WRIT’s Amiga Games is a software company. Amiga is restarting the Amiga brand through publishing retro video games on smartphones and tablets. WRIT’s Retro Infinity is a video game distribution site. It publishes video games from Amiga, Atari and other "retro" brands on contemporary smartphones, tablets and consoles.

Additionally, WRIT’s Pandora Venture Capital is a financial technology company. Pandora has an emphasis on its digital currency, Pelecoin, a new generation of digital currency, Blockchain technology solutions, and also the CrypFXPro trading platform. WRIT Media's proprietary CrypStock digital trading platform will provide the technology that will support the creation and trading platform for Pelecoin and other digital currencies.

WRIT Media Group plans to integrate its Pelecoin Blockchain technology into products and applications that can be used to make it as easy to spend digital currencies, cryptocurrencies, and Pelecoin, as it is to spend US Dollars. Through the Company’s acquisition of Pandora Venture Capital, WRIT assumed a skilled management team with backgrounds in payments, telecom, and digital currency.

Recently, WRIT Media Group announced a number of technology innovations within its Pelecoin cryptocurrency system. The Company plans over the next year to enhance its software platform through adding more features and by expanding its ecosystem through new products.

WRIT Media's development team has built the core functionality of its digital currency system. The Company now offers a new feature that enables users to mine four cryptocurrencies at the same time by employing Pelecoin's proprietary mining algorithm software. The core system is complete. The foundation is ready for Pelecoin to expand and become a strong platform suitable for broader adoption, with updated core features and extensive new ones for its ecosystem.

WRIT Media Group, Inc. (WRIT), closed Monday's trading session at $0.012, even for the day, on 2,206 volume with 8 trades. The average volume for the last 3 months is 11,946 and the stock's 52-week low/high is $0.0107/$0.029899999.

chart

The QualityStocks Company Corner

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com (OTCQB: CIIX) is employing its financial proficiency to establish itself as a leader in China’s emerging cannabidiol (“CBD”) industry. An article discussing the company reads, “Although cannabis is currently illegal in China, hemp-based CBD can be legally added to nutrition and health products and cosmetics, opening up massive opportunities in the untapped Chinese CBD market. CIIX has created a three-year development plan to pioneer an attractive lineup of CBD-based products through its subsidiary, CBD Biotech, and capitalize on the tremendous potential of the enormous Chinese market, where the benefits of CBD oil have not been widely recognized yet. To view the full article, visit http://cnw.fm/Ig7A6

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed Monday's trading session at $0.1499, up 8.231%, on 34,268 volume with 17 trades. The average volume for the last 3 months is 52,971 and the stock's 52-week low/high is $0.119999997/$0.51999998.

Recent News

chart

Predictive Oncology (NASDAQ: POAI)

The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).

Predictive Oncology Inc. (NASDAQ: POAI), a leader in the cancer precision-medicine field, along with its subsidiary TumorGenesis Inc., has announced an innovative special media for growing ovarian tumors; the companies have also selected US Biological Corporation as a manufacturer and distributor of the groundbreaking media (http://nnw.fm/2bdtl). POAI anticipates the new formulations, which will be developed in a lab, will speed discovery of biomarkers and precision therapies.

Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.

Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:

  • A database of clinically validated historical and outcome data from patient tumors
  • An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
  • A “smart” patient-derived tumor profiling platform
  • An in-house bioinformatics artificial intelligence (AI) platform
  • A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
  • An FDA-approved fluid collection and disposal system

Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.

Subsidiaries

Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.

Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.

In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.

TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.

Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.

Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.

Competitive Advantage

Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.

Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.

Leadership Team

Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.

CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.

Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.

Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.

Predictive Oncology (POAI), closed Monday's trading session at $2.35, up 7.7982%, on 92,262 volume with 436 trades. The average volume for the last 3 months is 139,211 and the stock's 52-week low/high is $2.11899995/$8.50.

Recent News

chart

SRAX Inc. (NASDAQ: SRAX)

The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

SRAX (NASDAQ: SRAX), a digital marketing and consumer data management technology company, today announced the release of a new case study. According to the update, the study illustrates results when one of the largest global food and beverage companies activated BIGtoken to drive sales during the 2019 holiday season. To view the full press release, visit http://nnw.fm/0ZjP8

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.

BIGtoken

BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.

Leadership

Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Monday's trading session at $2.95, up 0.340136%, on 57,495 volume with 317 trades. The average volume for the last 3 months is 99,888 and the stock's 52-week low/high is $1.04999995/$5.8499999.

Recent News

chart

Champignon Brands Inc.

The QualityStocks Daily Newsletter would like to spotlight Champignon Brands Inc.

Champignon Brands Inc. is a research-driven company specializing in the formulation and distribution of a suite of artisanal mushroom health supplements. Dedicated to revolutionizing conventional organic teas, coffees and other consumables with the infusion of a proprietary blend of artisanal mushrooms, Champignon’s expanding portfolio is crafted with the health-conscious consumer in mind. Headquartered in Vancouver, British Columbia, Champignon’s team aims to promote the health and wellness benefits of functional mushrooms, which are used in a wide variety of health care and pharmaceutical products.

Champignon Brands Inc. is a research-driven company specializing in the formulation and distribution of a suite of artisanal mushroom health supplements. Dedicated to revolutionizing conventional organic teas, coffees and other consumables with the infusion of a proprietary blend of artisanal mushrooms, Champignon’s expanding portfolio is crafted with the health-conscious consumer in mind.

Headquartered in Vancouver, British Columbia, Champignon’s team aims to promote the health and wellness benefits of functional mushrooms, which are used in a wide variety of health care and pharmaceutical products.

Brands

Champignon’s mushroom-derived consumer packaged goods (CPGs) portfolio includes its flagship brand, Vitality Superteas. Each carefully curated Vitality Supertea formulation was developed with the intent of helping individuals enhance and enrich their wellbeing one cup of mushroom-infused tea at a time.

Also in the portfolio are Nourish Force Supertea, a blend of Reishi Ryobus Tea Mix; Mighty Recharge Supertea, created with Lions Mane Tropical Green Ginseng Tea Mix; and Brain Enhance Supertea, a blend of Cordycep Hibiscus and Berries Tea Mix – all of which are formulated with organic ingredients and chosen for their ability to provide unique health and performance benefits.

Champignon’s flagship e-commerce store, VitalitySuperTeas.com, takes advantage of the burgeoning craft mushroom vertical space with a selection of mushroom-infused teas and accessories.

Global Market

Demand for consumer products infused with the nutritional and bioactive benefits of mushrooms is fueling a global market projected to reach $34.3 billion by 2024, growing at a compound annual growth rate of 8.04% from 2019-2024 (ResearchandMarkets), with Europe seen as the fastest growth leader.

According to the market study, in highest demand are products infused with Reishi – a traditional Chinese medicine also known as the “Elixer of Life” and “Mushroom of Immortality – Lions Mane and Cordyceps, followed by other types of medicinal mushrooms.

Advances in Legalization

Legalization of psychedelics for use in medicine is gaining momentum across the United States. Denver, Colorado, and Oakland and Santa Cruz, California, have decriminalized the use of psilocybin, the psychedelic molecule found in various mushrooms, while movements for legalization are gaining ground in Oregon and Iowa, among others. Decriminalize California recently teamed up with the Beckley Foundation to replicate Oakland’s success of decriminalization throughout the state of California.

An increasing number of researchers are turning their attention toward the study of psilocybin as a means to treat otherwise untreatable illnesses. The molecule’s ability to provide landmark treatment options for depression, post-traumatic stress disorder (PTSD), migraines and addiction is gaining widespread acceptance among medical professionals, unicorn investors and accredited institutions.

Potential Application: Mental Illness

According to the World Health Organization, 25% of the world’s populous will be afflicted by mental health and/or neurological disorders. Presently, approximately 450 million people currently suffer from such conditions, placing mental disorders among the leading causes of ill-health, productive loss and disability worldwide.

The mental health arena has been frequently neglected over the last 30 years, though new research is beginning to further reinforce that psychedelic compounds have the potential to produce more effective treatments than what is currently available. Psychedelics can be highly effective for treating depression, addiction and PTSD.

Partnerships

Companies worldwide are beginning to incorporate functional mushrooms into their product offerings, taking advantage of growing consumer awareness of known health benefits of the ingredients found in mushrooms.

Champignon in November 2019 entered into a distribution partnership with Eurolife Brands Inc. (CSE: EURO), a leading global markets cannabis brand empowering the medical, recreational and CPG cannabis industry worldwide through a data-driven CBD marketplace supported by exclusive and unbiased physician-backed cannabis education and detailed consumer analytics. Under the agreement, Champignon’s branded products are integrated into Eurolife’s e-commerce platform, along with potential distribution opportunities in select brick-and-mortar retail locations in Europe.

Champignon also has an R&D/production formulation agreement with Drip Coffee Social Ltd., located in Nanaimo, British Columbia, which calls for the infusion of Champignon’s proprietary mushroom extract blend into a suite of cold brew coffee products and signature in-house formulations.

Leadership

Gareth Birdsall, CEO, Corporate Secretary and Director
Gareth Birdsall has more than seven years of experience working in diverse agricultural roles such as the cultivation of various fungi, in particular Cordycepes, Reishi, Lions Mane and Chaga. He is an attendee of the British Columbia Institute of Technology, studying marketing management and finance.

Steven Brohman, CPA, CFO
Steven Brohman has more than 10 years of experience working in a variety of roles with public and private companies. He has had extensive training in the audit of publicly traded companies on the TXS, TSX Venture Exchange and OTC markets, and serves as CFO and director of various public and private companies. Brohman has a bachelor’s degree of business administration and obtained his Chartered Professional Accountant designation.

Jerry Habuda, Director
Jerry Habuda brings to Champignon over 35 years of expertise in law enforcement and specialized units. From 1977 to 2012, he served as a police officer with the Toronto Police Department. During his tenure, he was assigned to the Major Crimes Unit, investigating robberies and home invasions. He was assigned to patrol the Toronto Community Housing projects at Jane/Finch to control drug trafficking and gun violence. Habuda was with the Warrant Unit where he tracked down and arrested wanted criminals. From 1993-1997, he was assigned to the Northwest Drug Squad on undercover and surveillance work, executing narcotic search warrants. Between 2002 and 2004, Habuda headed the Street Violence Task Force, a special unit designed to curb gun and drug violence that was terrorizing the city at the time.


Recent News

chart

Trxade Group Inc. (NASDAQ: MEDS)

The QualityStocks Daily Newsletter would like to spotlight Trxade Group Inc. (NASDAQ: MEDS).

Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and sellers of pharmaceuticals, today announced the exercise by the underwriters of the Company’s previously announced firm commitment underwritten offering which closed on February 18, 2020. To view the full press release, visit http://nnw.fm/g3N0J

Trxade Group Inc. (NASDAQ: MEDS) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform (www.trxade.com) for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.

Trxade will leverage and scale its fully integrated model to execute the following growth strategies:

  • Increase share of pharmacist drug purchasing
  • Additional SKUs and expand product breath
  • Partner with Specialty and International Mfg.
  • Expand mail order licenses to all 50 states
  • Scale Delivmeds for consumer delivery nationwide
  • Integration with telemedicine
  • M&A Opportunities within drug value chain

Founded in 2010 and headquartered in Tampa, Florida, Trxade’s overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company’s pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.

Business-to-Business (B2B)

The $330 billion U.S. pharmaceutical industry is comprised of more than 65,000 pharmacy facilities and 1,500 state-licensed suppliers. Roughly 24,000 of these facilities are independent pharmacies, which collectively spend approximately $93 billion a year on branded and generic drugs.

Trxade targets these independent pharmacies, leveraging a robust, “E-Bay/Kayak-like” technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.

Trxade currently serves and transacts with more than one-third (10,250) of these independent pharmacies and facilitates over $10 million of drug purchases a month!

Consumer

Trxade also targets the “consumer side” of the pharmaceutical industry, aiming to lower prescription drug costs by attacking the inefficient value chain; offering drug price transparency and efficient buying; and, delivering drugs DIRECT to independent pharmacists and consumers.

The company operates a full-service mail order pharmacy for U.S. consumers, as well as a mobile app called “Delivmeds” (http://www.delivmeds.com) which enables SAME DAY home delivery of dispensed prescriptions.

Retail

Trxade’s Managed Services Organization (“TrxadeMSO”) enables its member independent retail pharmacies to get patients, process orders, and deliver or ship prescriptions to patients. TrxadeMSO provides access to encompassing network of pharmacies through the E-Hub software, allowing for timely and comprehensive medication fulfillment.

These offerings ensure the best-suited pharmacy receives the patient’s information, thereby ensuring appropriate medication coverage based on the patient’s location, payor coverage, and medication access/inventory. This will save the clinicians and their staff time as they benefit from efficiency and enhanced workflow management in script processing and fulfillment.

Health Care Market

The U.S. health care market currently hovers near $4 trillion and is expected to grow as the general population ages. This growth will have greater impact on consumers as out-of-pocket expenses also rise. Additionally, drug costs are paced to increase faster than the overall health care and well above inflation.

Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.

Trxade’s fair online market platform targets the nation’s retail community and independent pharmacies, of which there are approximately 24,000 nationwide. TRxADE has found that independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The TRxADE S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving money by taking advantage of best purchase pricing.

TRxADE’s programs include:

  • TRxADE Exchange, which opens and widens the distribution channel to the retail, community pharmacy. A purchasing pharmacy can view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. This approach significantly enhances the competitive spirit of the exchange where the lowest price exists for each product at any given point in time. TRxADE has become a competitive tool for all progressive entities and is recognized for its easy searching of hard-to-find generic pharmaceuticals at substantially reduced prices.  
  • RX Guru™ is an industry-leading price prediction model that integrates product shortage insight into pharmacy acquisition benchmarks (“PAC”) to ascertain trends and pricing variances that result in significant purchasing opportunities. RX Guru affords members the opportunity to continuously benefit from real price purchasing opportunities that are concealed from the rest of the industry. 
  • Product Shortage Database – TRxADE maintains the most comprehensive retail, specialty and acute care pharmaceutical product shortage database in the country. Other industry competitors mainly restrict their efforts to specialty and acute care product shortages and narrowly research oral generic products. TRxADE’s advanced prediction tools help members source those hard-to-find products at affordable costs in a timely and easy-to-search process. 

Management Team 

Trxade’s management team is rich in expertise within the pharmaceutical supply chain and is supported by a base of advisors and contractors who are experts in related fields of the pharmaceutical sector.

Suren Ajjarapu – Chairman of the Board, Chief Executive Officer and Secretary
Suren Ajjarapu has served as Trxade’s chairman of the board, CEO and secretary since 2014, and as the chairman of the board, chief executive officer and secretary of Trxade Nevada since its inception. Ajjarapu also serves as a chairman of the board for Feeder Creek Group Inc., since March 2018. Ajjarapu formerly was a founder, CEO and chairman of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest, United States; a founder, president and director of Aemetis Inc., a biofuels company (AMTX.OB); a founder, chairman and CEO of International Biofuels, a subsidiary of Aemetis Inc.; and a co-founder, COO, and director at Global Information Technology Inc., an IT outsourcing and systems design company. Ajjarapu holds an M.S. in environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in international finance and management. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.

Prashant Patel – Director, President and Chief Operating Officer
Prashant Patel has served as Trxade’s full-time president and COO, and as a director since the company’s acquisition of Trxade Nevada in 2014, and as the COO and president and as a director of Trxade Nevada since its inception. He has been a president and member of the board of Trxade since August 2010. Patel is a registered pharmacist and pharmaceutical consultant with over 10 years of experience in retail pharmacy and pharmaceutical logistics. He is the founder of several pharmacies in the Tampa Bay area, in Florida. Since 2008, Patel has been managing member of the APAA LLC pharmacy. Since 2007, Patel has been a vice president of Holiday Pharmacy Inc. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, UK.

Trxade Group Inc. (MEDS), closed Monday's trading session at $6.85, off by 5.5172%, on 25,306 volume with 155 trades. The average volume for the last 3 months is 106,950 and the stock's 52-week low/high is $2.0999999/$10.5600004.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Legal cannabis spending worldwide increased from $10.2 billion in 2018 to $14.9 billion in 2019, making for a 45.7% increase driven primarily by the adult-use markets, reports the Arcview Group, a market research firm that specializes in cannabis. Arcview is now forecasting sales worldwide to reach $42.7 billion by 2024. This is exciting news for Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF), an edible cannabis company that has sustained its position of number one gummy brand for more than six quarters in California, one of the most competitive cannabis markets in the world.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed Monday's trading session at $0.7781, off by 4.1158%, on 69,188 volume with 61 trades. The average volume for the last 3 months is 42,081 and the stock's 52-week low/high is $0.730000019/$5.77449989.

Recent News

chart

Sigma Labs Inc. (NASDAQ: SGLB)

The QualityStocks Daily Newsletter would like to spotlight Sigma Labs Inc. (SGLB).

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D printing industry, today announced that management will present at the LD Micro Virtual Investor Conference at 1:00 p.m. Eastern Time on March 4, 2020. According to the update, Sigma Labs Executive Chairman, Mark K. Ruport, will present an overview of the business model and growth initiatives. A presentation will accompany the webinar, which will be followed by a question and answer session. To access the webinar, visit http://nnw.fm/m824P. To view the full press release, visit http://nnw.fm/K9ouK.

Sigma Labs Inc. (SGLB) is the only provider of in-process quality-assurance software to the commercial 3D printing metal industry that enables operators of machines making 3D metal parts to offset emerging quality problems, sustain part quality, and avoid rejects. Sigma’s software is the singular solution that enables both real-time, in-process detection of quality control manufacturing irregularities for critical metal parts and then provides the operator the actionable information needed to adjust and mitigate the developing anomaly. Sigma Labs’ software represents a paradigm shift in the quality control process for the manufacture of 3D printed metal components. The nascent 3D metal printing industry is on the verge of radically altering the speed and technical complexity of manufactured parts. Further, it makes possible just-in-time availability of critical components – all at reduced cost, time, waste and weight. 3D printing, heralded as the fourth industrial revolution in manufacturing, will only truly surpass traditional techniques when the additive manufacturing industry moves from “post process” quality control to “in process” quality assurance.

For the industry to move from prototype manufacturing of critical components to economically viable commercial production, the 3D metal printing industry must find ways to dramatically increase production speed and quality yields, and to dramatically decrease the excessive cost of quality control. To achieve these prerequisites and move 3D metal printing into the mainstream, parts must be inspected and certified during the manufacturing process rather than after. Parts in the production process that are developing signs of quality control problems must be identified in real-time and alerts must be issued. The problem, along with the solution, must then be communicated to the machine operator to implement repairs.

Revolutionizing Additive Manufacturing

Sigma Labs, with its PrintRite3D® brand, has established a new benchmark in the development and commercialization of real-time computer aided inspection (“CAI”) solutions. Sigma Labs resolves the major roadblocks and costly quality control challenges that impede the 3D manufacture of precision metal parts. The company’s breakthrough computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance during production, uniquely allowing errors to be corrected in real-time.

Sigma Labs was founded in 2010 by a team of Los Alamos National Labs scientists and engineers to develop and commercially license advanced metallurgical products for the military ordinance, dental implants, and then for additive manufacturing (3D printing). After assessing 3D metal printing technology and the costly, inconsistent quality control issues, Sigma Labs concluded that the enormous potential of 3D metal printing could only scale up if in-process quality-assurance tools were developed to observe, manage and control the manufacturing complexities in such a manner that reliability and repeatability of very high precision quality metal parts could be achieved in the process. Sigma Labs’ patented and third-party validated software has achieved these objectives and now delivers the critical elements needed to unleash the promise of 3D metal printing.

Sigma Labs’ products and services are engineered, manufactured and qualified for use in the highly demanding and hyper precise production environments of the aerospace, defense, transportation, oil and gas, biomedical and other precision-dependent industries.

The Challenge

Additive metal manufacturing combines multiple processes and parts into one single 3D printed part. Due to variances in the additive manufacturing process, parts of consistent quality currently can’t be reliably produced in either large or small quantities without substantial postproduction inspection and rejection costs. Parts are inspected after production using CT scans and other means, so the manufacturer doesn’t know until the very end which of the finished parts meet design specifications. This means lost time, lost profits and inability to economically scale up production.

Innovative Approach

Sigma Labs solves this problem with its patented, in-process quality control technology that informs operators and engineers how to improve both the manufacturing process and quality by capturing meaningful data about inconsistencies in real-time. Sigma Labs is also partnering with OEMs, working toward the visionary introduction of revolutionary closed-loop control that will bypass the machine operator and automatically make in process corrections by reducing machine variations.

Sigma Labs’ next generation technology gives manufacturers the ability to make fast, virtual real-time adjustments so that each finished part is uniform and within critical specifications, thereby improving production quality, decreasing end-users’ risks and waste, and increasing profits and speed to market. Sigma Labs’ PrintRite3D® IPQA Software monitors and assesses the quality of each production part in the 3D additive manufacturing process – layer by layer, and in real-time. This has never been available until now.

Sigma Labs maintains a strong intellectual property portfolio consisting of trade secrets, process know-how and 34 patents either granted, pending or awaiting pre-publication around the globe. These patents encompass the fundamental technologies underlying Sigma Labs’ melt pool process control, data analytics, anomaly detection, signature identification, and future “closed-loop control” of 3D metal printing.

Market Opportunity

Providing advanced quality assurance software to the commercial 3D printing industry is currently a $1.4 billion addressable market expected to grow to $3.9 billion by 2023. Integrating Sigma Labs’ groundbreaking software helps arm the industry with a necessary catalyst to help enable and optimize the fourth industrial revolution in manufacturing.

Sigma Labs’ global client base includes 23 installations across 19 different users. Tier-1 OEM enterprises and end-users such as Siemens, Honeywell, Pratt & Whitney and others are currently evaluating PrintRite3D® for production lines.

Management Team

John Rice, CEO and chairman of the board of directors, has extensive experience as a CEO, lead negotiator, turnaround expert, business financier and crisis management executive/consultant. Prior to becoming chair and CEO of Sigma Labs, he was the CEO of a successful turn-around of a Coca-Cola Bottling Company. Rice has led a variety of companies in diverse business sectors and worked on a host of products and technologies including design and manufacture of high-end jet engine test equipment for the U.S. Airforce, chaff dispensers for F16s, software for modeling naval exercises, software for controlling warehouse distribution systems, medical radioisotopes, cancer detection, and cybersecurity. He is an honor’s graduate of Harvard College.

Darren Beckett, CTO, has over 20 years of experience in the semiconductor industry, including Intel Corporation, where he held various technical and managerial positions. His expertise in process engineering for advanced manufacturing technology includes statistical process control for fabrication of semiconductor devices.

CFO Frank D. Orzechowski also serves as treasurer, principal accounting officer, principal financial officer and corporate secretary. He has more than 30 years of distinguished financial and operational experience. Orzechowski began his career at Coopers & Lybrand in 1982, received his CPA certification in 1984, and received his Bachelor of Science in Business Administration with a major in accounting from Georgetown University in 1982.

Ronald Fisher, vice president of business development, is leading the commercialization of PrintRite3D® 5.0. Fisher is a mechanical engineer with hands-on experience in quality, manufacturing and product development. He has distinguished himself as a lead sales and marketing officer as well as a chief operating officer most recently before joining Sigma in technology startup that grew from market entry to successful exit by merger-acquisition.

Sigma Labs Inc. (SGLB), closed Monday's trading session at $0.6097, off by 10.4041%, on 121,380 volume with 262 trades. The average volume for the last 3 months is 94,385 and the stock's 52-week low/high is $0.451099991/$2.16000008.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) was featured today in a publication from HempWireNews, examining how the World Agriculture Expo is the largest annual outdoor agriculture exposition, with over 1,450 exhibitions and 100,000 plus attendees every year. This year, hemp fever was high. Although the crop has been legal for a little more than a year and the hemp industry is still in its infancy, the cash crop was big during the 2020 Ag Expo.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary DehydraTECH™ technology for improved taste, rapidity and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECH technology to improve taste, remove odor and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada and the United States. Lexaria has also developed its own hemp-oil brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea and supplements. These brands include ViPova™, TurboCBD™ and ChargD+™.

Virtually unique across both the hemp and the cannabis industries, Lexaria has successfully entered into a R&D and product development partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Only a small handful of hemp or cannabis-related companies have achieved formal relationships with Fortune 500 industry leaders, demonstrating the wide applicability of Lexaria’s technology.

In June 2019, building on its original 2015 independent, third-party laboratory in vitro lab experiments, which confirmed the absorption levels of cannabidiol (“CBD”) into human intestinal cells rose by 499% through the utilization of the DehydraTECH technology, Lexaria completed a series of animal studies using an enhanced formulation of its DehydraTECH technology. The results of the animal studies using the enhanced DehydraTECH formulation showed an increase of CBD delivery into the blood when compared to generic industry MCT coconut-oil formulations by 811%. In addition, the animal studies also showed delivery of 1,937% more CBD into animal brain tissue after 8 hours using the enhanced DehydraTECH technology when compared to generic industry MCT coconut-oil formulations.

Lexaria also has completed the first phases of its collaborative research program with the Canadian government’s National Research Council (the “NRC”) under which several studies were designed to optimize Lexaria’s DehydraTECH technology, enabling delivery of API’s within foods, beverages, capsules and other ingestible formats. These studies investigated the lipophilic active agent classes including cannabinoids, vitamins, NSAIDs and nicotine using advanced analytical techniques, including mass spectrometry and nuclear magnetic resonance testing, with the results of the studies confirming that Lexaria’s DehydraTECH technology did not create any covalent-bonded new molecular entity (“NME”). Whenever an NME is created, regulatory bodies such as FDA and Health Canada routinely require extensive health, safety and efficacy studies prior to that product’s release into the marketplace. That the NRC program failed to find evidence of an NME suggests products utilizing the DehydraTECH technology may require a less burdensome regulatory pathway.

Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: hemp/CBD; pharmaceutical; cannabis; and nicotine. In August 2019, Lexaria was issued its cannabis research and development licence from Health Canada which will allow Lexaria to continue its further investigations in-house of its DehydraTECH technology in connection with cannabinoids, along with ongoing work with vitamins, NSAIDs, PDE5-inhibitors, nicotine and other molecules.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the August 2019, the company’s patent portfolio includes ~60 patent applications filed and pending in more than 40 countries around the world; and 16 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally by the end of 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others. Lexaria’s granted patent portfolio related to cannabinoid delivery is one of the largest in the world.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology to third-partners and has signed licensing agreements with start-up companies as well as with a Fortune 100 industry leader. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed Monday's trading session at $0.46, off by 4.1667%, on 49,819 volume with 41 trades. The average volume for the last 3 months is 97,785 and the stock's 52-week low/high is $0.3037/$1.52999997.

Recent News

chart

MCTC Holdings Inc. (OTC: MCTC)

The QualityStocks Daily Newsletter would like to spotlight MCTC Holdings Inc. (MCTC).

MCTC Holdings Inc. (OTC: MCTC) was featured today in a publication from CBDWire, examining how the cannabidiol craze won’t stop anytime soon. Also known as CBD, the chemical has become extremely popular in the medical, sports, health and wellness communities. CBD is extracted from hemp, and like most of the cannabinoids produced by hemp, it is a potent medicine. Also today, CannabisNewsWire released a report on the company detailing how MCTC is building on its recent advances in cannabinoid product science, will make a splash with its public debut of the company’s new Hemp You Can Feel(TM) Coffee at the White Label World Expo (United States) in Las Vegas later this month.

MCTC Holdings Inc. (OTC: MCTC) is an innovator in the field of cannabinoid nanoparticles and infusion technologies with several important cannabinoid patents filed and an active research and development program underway. The company was reorganized during June of 2019 and announced its intent to enter the cannabis sector and change its corporate identity to Cannabis Global Inc. The company is headquartered in Los Angeles, California.

With the hemp and cannabis industries rapidly expanding in terms of market size, acceptance and number of market participants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company is actively pursuing R&D programs and productization of advanced cannabinoid delivery systems, based on solid polymeric nanoparticles and fibers. These technologies hold the promise to revolutionize the science of cannabinoid bio-enhancement for use in foods, beverages, consumer products and in transdermal applications. Because of nanoparticles’ ability to be quickly absorbed into the bloodstream, nanotechnology has been utilized in the food and drug industry for some time and has the potential for tremendous growth in the cannabis industry (http://nnw.fm/v6RQ6).

Cutting-Edge Technology

MCTC is at the cutting-edge of the cannabis industry’s trends with its emphasis on polymeric nanotechnology. This is not to be confused with the more basic oil-in-water nano-emulsions currently marketed to the food and beverage industry. The company’s polymer-based particles offer significant loading of active ingredients and unmatched flexibility and customization, allowing for myriad combinations of cannabinoids with unique performance characteristics. MCTC believes polymeric nanotechnology particles will be a critical technology area for the cannabinoid formulation marketplace.

The company continues to build its R&D program, specifically researching the development of improving methods to make cannabinoids available to living systems. Instrumental in the research program is the development of novel polymeric nanoparticles and nanofibers. These have the potential to elevate the potential of cannabinoid products in the following ways (http://nnw.fm/cK3Bl):

  • Significantly improving bioavailability
  • Allowing for ultra-high loading rates
  • Enhancing customization of cannabinoid combinations
  • Improved dosing precision
  • Providing more control in release parameters

MCTC leadership understands the importance of developing intellectual property (IP) in the ever-evolving cannabis industry. A recent Forbes article described IP as “critical for creating true differentiation between companies and their product and service offerings” (http://nnw.fm/57Fjh). Recognizing the importance of IP, MCTC has been consistent in its application for patents to protect its innovative nanotechnology applications.

Patents

MCTC has now filed four patents on its cannabinoid delivery technology systems:

  • The company first collaborated with Cannabis Nanosciences Inc. on technologies. This became the basis for its first patent filing on an innovative edible dissolvable film for cannabinoid ingestion.
  • Its second patent filing for cannabinoid nanoparticles combined TPGS, a water-soluble form of vitamin E.
  • Its third patent filing involved a unique 4th dimension, 3D printed cannabinoid delivery system for beverages.
  • Its fourth patent, considered its most significant, broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially within a water-soluble medium.

Collaborations

MCTC collaborated with Marijuana Company Inc. (OTCQB: MCOA) subsidiary hempSmart Inc., under a hemp extract and CBD product supply agreement wherein hempSmart will utilize its extensive network of marketing partners to market MCTC’s powered drink mixes and other CBD edibles online. These products are designed for the dry beverage and edibles sector and will be supplied by MCTC. They incorporate the company’s patent-pending cannabinoid infusion technologies and will be trademarked as Hemp You Can Feel (TM) and Gummies You Can Feel (TM).

Leadership

MCTC CEO and chairman Arman Tabatabaei boasts 15 years of management and operations experience and is considered an expert at data collection and analysis relative to resource management, risk forecasting, and profit and loss management. He has acted as a consultant with Cannabis Strategic Ventures (OTCQB: NUGS) and played an instrumental role in improving operations at Sugarmade Inc. (OTCQB: SGMD) relative to the company’s hydroponic growth supplies initiatives.

MCTC founder and director Robert Hymers also brings a seasoned perspective, having had significant experiences in the cannabis industry and as a financial executive and consultant. He is the managing partner of Pinnacle Tax Services in Los Angeles and was previously CFO and director of Marijuana Company of America Inc. (OTC: MCOA). He is currently a member of the Strategic Advisory Board at Massroots Inc. and acts as a consultant to both Cannabis Strategic Ventures Inc. and Sugarmade Inc. Hymers’ background in tax accounting, auditing, SEC reporting, mergers and acquisitions, and corporate finance has immense value in his current position at MCTC Holdings.

MCTC Holdings Inc. (MCTC), closed Monday's trading session at $0.30, off by 9.0909%, on 12,808 volume with 6 trades. The average volume for the last 3 months is 17,510 and the stock's 52-week low/high is $0.05/$3.00.

Recent News

chart

Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE)

The QualityStocks Daily Newsletter would like to spotlight Pacific Rim Cobalt Corp. (OTCQB: PCRCF).

Pacific Rim Cobalt (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE)today announced that it has changed its name to Bolt Metals Corp., with an effective date on or about February 26, 2020. The Company’s shares will continue to trade under the stock symbol "BOLT" on the Canadian Securities Exchange (“CSE”). Similarly, there will be no change to the Company’s trading symbol on the Frankfurt Exchange or the OTCQB. To view the full press release, visit http://nnw.fm/C7G6z

Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) is a Canada-based exploration company focused on the acquisition and development of production-grade battery metals deposits within the Asia-Pacific region, employing a vertically integrated “minerals-to-market” strategy to leverage these assets to their fullest.

Pacific Rim Cobalt Corp. is advancing its flagship, 100% controlled Cyclops Nickel-Cobalt located in Papua Province, Indonesia with a mandate to become a key contributor to Asia-Pacific’s rapidly expanding electric vehicle and battery supply chain.

The Cyclops project, uniquely positioned within the world’s largest producer of nickel and in proximity to China, the world’s largest “Gigafactory”, features near surface, strong nickel-cobalt mineralization. The property is situated in an area with excellent infrastructure including a nearby workforce, supplies, sealed roads, ocean access, nearby port facility and gentle topography. The project area, nestled on the north coast of Papua, Indonesia, establishes Pacific Rim Cobalt well within the economically attractive ocean-going transportation range to Asia and its lucrative, growing industrial markets.

Global demand for renewable power is fueling a massive shift from traditional energy supply chain economics to nickel-reliant lithium-ion batteries, the world’s most widely used power source for portable applications such as electric vehicles and other high-tech applications.

Indonesia has recently approved environmental impact studies for factories to produce battery-grade nickel chemicals in Morowali. The approval will allow investors, such as China’s stainless steel giant Tsingshan Group, to continue the construction of their high-pressure acid leaching plants in Morowali, Central Sulawesi.

Ranjeet Sundher, chief executive officer of Pacific Rim Cobalt, said: “Indonesia continues to make significant strategic decisions, and this latest announcement represents an important step in Pacific Rim Cobalt’s efforts to benefit from Indonesia’s rapid development as a leading market for all stages of the EV supply chain. With offices in Vancouver, Shanghai and Jakarta, Pacific Rim Cobalt is well positioned to leverage Asia’s global dominance in the battery manufacturing sector.”

Indonesia’s commitment extends to the very top of government, with Joko Widodo – Indonesia’s President – stating in September 2019 that “for nickel, we want raw materials to be processed in Indonesia. We want added values”. This supports previous pronouncements from key officials, including Indonesian Maritime Minister, Luhut Pandjaitan who remarked that Indonesia will “become the main player in lithium batteries” and that it will “control the world market”.

The country, which is the world’s top nickel ore exporter, has stopped export of unprocessed nickel ore to support this plan.

During 2019 the Company carried out an extensive exploration and development program on Cyclops and achieved successful nickel results with its drilling and bench-scale scoping tests for processing of materials.

Drilling identified significant horizons of nickel mineralization and bench-scale scoping tests returned positive results for processing of this nickel rich material.

The recovery percentages form the bench-scale test program are set out below (for further information, please refer to the Company’s press release of October 28, 2019):

Sample Nickel (%) Cobalt (%) Iron (%)
Limonite 99.26 98.82 97.77
Low Iron Transition 99.75 97.03 99.22
Saprolite 99.77 >99.9 99.74

 

Selected elevated nickel drill results are provided below from the Company’s shallow drilling program (for further information, please refer to the Company’s press releases of March 5, April 1, April 23, June 13, June 20 and September 10, 2019):

Intersection length (metres from surface) Nickel (%) Cobalt (%)
7.0 2.15% 0.03%
4.0 1.96% 0.04%
2.0 2.00% 0.01%
2.0 1.91% 0.05%

 

2020 will see continued and consistent development in Pacific Rim Cobalt’s strategy as the company continues to set ambitious milestones with the goal of becoming a leading international player in the EV battery metal sector and creating significant long-term shareholder value.

This includes preparations to commission and operate the company’s pilot plant in Canada, which will contain an integrated circuit to produce high-purity nickel and cobalt strip solutions to develop battery-grade nickel and cobalt.

The results of the pilot plant will then be used to establish the design criteria for the subsequent demonstration plant in Indonesia, which will produce nickel and cobalt products suitable to meet market specifications. As well as demonstrating Pacific Rim Cobalt’s ability to produce a product within market specifications, this will also be used to establish the design criteria for the company’s commercial-scale plant.

Pacific Rim Cobalt’s world-class management team includes Ranjeet Sundher, who has over 20 years of capital markets experience. Sundher is also president of Canrim Ventures Ltd., a Singaporean advisory firm specializing in early stage project finance and structure. He previously founded Indogold Exploration, a Jakarta-based mining service firm, and has raised over $40 million for companies in which he was a founder/partner.

Chief Financial Officer Steve Vanry has 25 years of professional experience in senior management positions with public and private natural resources companies, providing expertise in capital markets corporate finance, mergers and acquisitions, regulatory compliance, accounting and financial reporting.

Andre Talaska serves as country manager and technical supervisor. He has over 30 years of experience in the mining and exploration industry and has held senior positions with several companies in Australia and southeast Asia. Shakir Juffry, business development/engineering, is a chemical engineer and extractive metallurgist by background training who has over 20 years of experience in the Indonesian mining and minerals exploration field. Toto Suarto Sajali, operation and development manager, is a mining engineer with over 15 years of experience in Indonesian project assessment, development and operations.

Pacific Rim Cobalt Corp. (OTCQB: PCRCF), closed Monday's trading session at $0.17, off by 17.9735%, on 243,627 volume with 42 trades. The average volume for the last 3 months is 24,560 and the stock's 52-week low/high is $0.079999998/$0.259299993.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint Inc. (OTCQB: SING) CFO Corey Lambrecht featured on Cleantech and Climate Change Podcast overviewing the overall company direction. Direct Solar America has announced the unaudited numbers for 2019 in which the entity achieved over $2,000,000 in just six months of operations. The following podcast can be listened to at this link - Link To Audio File. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. Two medical marijuana doctors are under investigation after Florida health officials filed a complained against them based on information obtained by undercover investigators posing as patients. A lawyer representing one of the doctors termed it as a trap.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Monday's trading session at $0.0104, off by 5.4545%, on 6,210,670 volume with 154 trades. The average volume for the last 3 months is 3,825,834 and the stock's 52-week low/high is $0.007/$0.023.

Recent News

chart

Nightfood Holdings, Inc. (OTCQB: NGTF)

The QualityStocks Daily Newsletter would like to spotlight Nightfood Holdings, Inc. (NGTF).

Nightfood Holdings (OTCQB: NGTF), the better-for-you ice cream company addressing America’s $50 billion-dollar nighttime snacking market, has announced that the American Pregnancy Association (“APA”) is now formally recommending Nightfood as the ice cream expectant women should turn to when experiencing pregnancy-related cravings. To view the full press release, visit http://nnw.fm/ig8gD

Nightfood Holdings, Inc. (OTCQB: NGTF), a pioneering consumer goods brand development company headquartered in Tarrytown, New York, owns Nightfood, Inc., creator of delicious, award-winning and better-for-you ice cream formulated by sleep and nutrition experts, and its wholly owned subsidiary MJ Munchies, Inc., which seeks to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. Known as “The Nighttime Snack Company,” Nightfood Inc. is focused on improving late-night snacking for consumers and solving America’s $50 billion-dollar nighttime snacking problem.

Nightfood Ice Cream

Nightfood’s higher-protein and sleep-friendly ice cream won the 2019 Product of the Year Award in the ice cream category in a Kantar survey of over 40,000 consumers. The annual Product of the Year survey, the world’s largest consumer-voted award for product innovation, is conducted by Kantar, a global leader in consumer research. In beating out the other finalists, consumers indicated that Nightfood’s one-of-a-kind innovation and unique value proposition made it a clear-cut winner in the ice cream space and a brand they were highly motivated to try.

Nightfood has secured distribution in several major regional supermarket chains and has landed media coverage in major outlets such as The Today Show, The Wall Street Journal, Oprah Magazine, USA Today, The Washington Post, Parents Magazine, and many more.

Over 80% of consumers snack regularly at night, and the most popular choices are cookies, chips, candy, and, of course, ice cream. These are understood to be both unhealthy and sleep-disruptive.

Research indicates that human biological programming combined with the trappings of modern life combine to drive this unhealthy behavior pattern. Every week, hundreds of millions of Americans combine to spend an estimated $1B on snacks consumed between dinner and bed.

In a recent Harris Poll online study, 54% of consumers who snack at night reported often feeling guilty about their nighttime snack choices. 58% said they wish they felt more in control of their nighttime snacking.

Nightfood management believes that the company that solves this massive consumer problem can become a national brand with a billion-dollar valuation.

Formulated by leading sleep and nutrition experts, including America’s most prominent sleep expert, Dr. Michael Breus, Nightfood’s higher protein/higher fiber, and lower sugar ice cream delivers great ice cream taste and texture, while minimizing sleep-disruptive ingredients such as caffeine, excess sugar, and excess fat and calories. The addition of certain minerals, enzymes and amino acids, which research suggests can support sleep quality, is another bonus. Nightfood only uses hormone-free milk, is certified Kosher, and offers eight original flavors, five of which are gluten-free. Nightfood ice cream also uses all-natural sweeteners with no Erythritol, no sucralose, or other artificial sweeteners.

Nightfood has developed a dynamic infographic resource that clearly illustrates the size and scope of the largely untapped nighttime snack category (http://NightSnacking.com). Americans everywhere are likely to identify with the infographic’s results that vividly illustrate late night snacking by age group, popular snack choice, and amount of money spent each week on feeding after-hour snack attacks. Available in eight delicious flavors, Nightfood ice cream can help consumers satisfy nighttime cravings in a better, healthier, more sleep-friendly way.

MJ Munchies, Inc.

MJ Munchies, Inc. was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company is seeking licensing opportunities to market such products under the brand name “Half-Baked,” for which they’ve successfully secured trademark rights.

Management Team

Nightfood founder and CEO Sean Folkson is a formerly frustrated nighttime snacker whose late-night cravings led him to seek a better solution for himself and others through the creation, marketing and distribution of the Nightfood product line. Folkson also founded internet marketing company AffiliatePros.com which provided the startup capital to launch Specialty Equipment Direct, an online distributor of floor removal equipment that quickly grew to 7-figure revenues. Folkson received a bachelor’s degree in business administration with a concentration in marketing from S.U.N.Y Albany, New York, in 1991.

Jim Christensen, vice president of Nightfood Ice Cream, is the former vice president of Ice Cream Sales with global ice cream giant Unilever. In his over 20 years at Unilever, Christensen led sales and distribution initiatives for brands such as Ben & Jerry’s, Klondike, Breyers and Good Humor. Christensen joined the Nightfood team in June of 2018 with the directive to launch Nightfood ice cream rapidly into national distribution. Understanding that the overwhelming majority of at-home ice cream consumption occurs in the hours before bed, Christensen has identified Nightfood as the next evolution in better-for-you ice cream.

CFO Mark Noffke, CPA, has over 37 years of experience as a seasoned financial and management professional. He has served as chief financial officer of several small-cap public companies since 2004 where he oversaw virtually every aspect of the company’s operations, administration, customer service and human resources. Noffke has a bachelor’s degree in accounting from Valparaiso University in Indiana.

Advisory Board

The Nightfood advisory board includes Tom Morse, founder of 5-Hour Energy and Living Essentials, LLC.; Doron Stern, former vice president of marketing at Chobani and Popcorn, Indiana; restaurateur and celebrity Chef Chris Santos; Paul Jarrett, CEO of fast-growing nutrition startup BuluBox; Eric Egeland, president of Capacity Consulting Inc.; Dr. Michael A. Grandner, director/Sleep and Health Research Program at the University of Arizona; Dr. Michael Breus, sleep expert and best-selling author known to millions as The Sleep Doctor(TM); Dr. Lauren Broch, resident nutrition, sleep disorder expert and a member of the scientific advisory board.

Nightfood Holdings, Inc. (NGTF), closed Monday's trading session at $0.369, up 10.1493%, on 470,681 volume with 170 trades. The average volume for the last 3 months is 121,146 and the stock's 52-week low/high is $0.187999993/$0.920000016.

Recent News

chart

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) ("GGB" or the "Company") announced today that The BRN Group Inc. ("BRN") has agreed to acquire (the "CBD Transaction") the Company's cannabidiol business (the "CBD Business").  The Company and an affiliate of BRN (the "Purchaser") have executed a "stalking horse" asset purchase agreement (the "Stalking Horse Agreement") in respect of the CBD Transaction pursuant to which the Purchaser will acquire all of the assets and assume the current liabilities and certain other obligations of the CBD Business. It is anticipated that the Company will hold up to a 20% carried interest in the CBD Business following completion of the CBD Transaction. Also today, the company reported its results for the period ended December 28, 2019. Revenues for the period totaled $21.1M.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed Monday's trading session at $0.3196, up 5.5134%, on 575,001 volume with 288 trades. The average volume for the last 3 months is 405,100 and the stock's 52-week low/high is $0.176200002/$4.86000013.

Recent News

chart

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF)

The QualityStocks Daily Newsletter would like to spotlight Siyata Mobile Inc. (SYATF).

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) was featured today in by Virtual Investor Conferences, the leading proprietary investor conference series, which today announced that the presentations from the February 20th conference are now available for on-demand viewing at VirtualInvestorConferences.com. REGISTER OR LOGIN NOW AT:  https://tinyurl.com/022020VIC-Agenda-PR

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) is a leading global developer and provider of Push-to-Talk Over Cellular ("PTT/PoC") systems for enterprise customers. The company specializes in connected vehicle products for professional fleets and markets its products under the Uniden® Cellular brand.

Since its inception in 2012, Siyata has amassed a customer base that includes cellular operators, commercial vehicle technology distributors, and fleets of all sizes in Canada, the U.S., Europe, Australia and the Middle East.

Recognized by the Toronto Venture Stock Exchange in 2018 as a Venture Top 50 Company, Siyata aims to deliver the highest quality and most technologically advanced mobile communication devices for global corporate workforces, fleets, homes and buildings.

The company has long been an industry pioneer, delivering the world's first 3G connected vehicle device as well as the world's first 4G/LTE vehicle mounted smartphone for First Responders and commercial fleets and vehicles.

Siyata is headquartered in Montréal, Québec, Canada.

Product Portfolio

Siyata's suite of technology includes numerous PTT and legacy devices, as well as cellular boosters designed to improve cellular signals in corporate warehouses, government embassies, retirement home campuses, banks and manufacturing plants.

The company's flagship product, the Uniden UV350, is the world's first vehicle-mounted 4G/LTE smartphone with crystal clear quality, carrier grade PTT, voice, text, video and data applications built into a single device. Specifically designed for First Responder and commercial fleet vehicles, the UV350 runs on cellular LTE networks that provide nationwide and global coverage, replacing traditional single purpose two-way radios that require a monthly fee and limited network coverage.

The Uniden UV350 is currently available through Bell Mobility, Canada's largest LTE network and PTT community. Expanding its availability, Siyata is completing network approval with two North American Tier 1 operators to launch the UV350 in the U.S. in 2019.

Management Team

CEO and Chairman Marc Seelenfreund is the founder of Siyata. He is also the founder of Siyata's parent company, Accel Telecom, an Israel-based company that specializes in importing and distributing innovative cellular and IP devices to fixed line operators and mobile providers within Israel. Prior to establishing Accel, Seelenfreund was a vice president at Sunrise Corporation in New York where he focused on financing publicly traded technology companies. Seelenfreund has a law degree from Bar Ilan University, is a board member at Israel's leading private university, and has served as an officer in the Israel Defense Forces.

Glenn Kennedy, vice president of sales, has over 25 years of sales experience in the telecommunications industry. Prior to joining Siyata in 2016, Kennedy managed sales nationally for Motorola Canada, HTC Communications Canada, and Sonim Technologies. He holds a bachelor's degree in honors business administration from the Richard Ivey School of Business at the University of Western Ontario.

CFO Gerald Bernstein, a professional chartered accountant, has spent 20 years focusing on private equity financing and tax efficient corporate structuring in multi-jurisdictional arenas. He holds a bachelor's degree of commerce as well as a graduate diploma in public accountancy from McGill University. Bernstein has been a member of the Canadian Institute of Chartered Accountants since 1987.

Gidi Bracha, Vice President of Technology, has served in this position since 2011 and spearheaded the development of both the Truckfone, Voyager and UV350. Bracha served in various key positions at Cellcom, Israel's leading cellular provider, including head of car mobility products and director of type approvals. Bracha served as an engineer technician in the Anti-Aircraft division of the Air Force in the Israel Defense Forces and holds a bachelor's degree in engineering and business management from the University of Derby.

Siyata Mobile Inc. (SYATF), closed Monday's trading session at $0.2232, off by 13.7891%, on 1,203,395 volume with 111 trades. The average volume for the last 3 months is 142,813 and the stock's 52-week low/high is $0.198500007/$0.446249991.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.